- Medicine Name: Kerendia
- Generic Name: Finerenone
- Dosage Form & Strength: Tablets: 10 mg and 20 mg
- Manufactured By: Bayer HealthCare Pharmaceuticals Inc.
Kerendia is a non-steroidal mineralocorticoid receptor antagonist (MRA) used to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospital stay for heart failure in adult individuals with chronic kidney disease associated with type 2 diabetes (T2D).
Recommended Dosage: The recommended starting dosage of Kerendia tablets is 10 mg or 20 mg orally once daily with or without food on behalf of estimated glomerular filtration rate (eGFR) and serum potassium thresholds. Kerendia dosage can be scaled up after four weeks to the target dose of 20 mg once daily, on behalf of estimated Glomerular Filtration Rate (eGFR) and serum potassium thresholds.
Those who are not capable of swallowing whole tablets, Kerendia may be crushed and mixed with water promptly prior to use and administered orally.
In case of a missed dose, the prescribed dose should be taken as quickly as possible before the very next scheduled dose. Do not take a couple of doses on the very same day to catch up for a missed dose.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.